Previous Statements by MYL
» Mylan's CEO Discusses Q1 2011 Results - Earnings Call Transcript
» Mylan's CEO Discusses Q4 2010 Results - Earnings Call Transcript
» Mylan Q3 2010 Earnings Call Transcript
Here's what moving in the world of Biotech
The result was due largely to a 'just vote no' campaign against the directors.
The company's chairman and director received stiff investor opposition at the company's annual shareholder meeting last week.